phosphatidylcholines has been researched along with norleucine in 2 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (norleucine) | Trials (norleucine) | Recent Studies (post-2010) (norleucine) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 497 | 2 | 95 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kinnunen, PK; Tuominen, EK; Wallace, CJ | 1 |
Briand-Mésange, F; Chap, H; Gaits, F; Granci, V; Gueguen, G; Klaébé, A; Rogalle, P; Salles, JP; Simon, MF; Tercé, F; Wilson, M | 1 |
2 other study(ies) available for phosphatidylcholines and norleucine
Article | Year |
---|---|
The invariant ARG91 is required for the rupture of liposomes by cytochrome C.
Topics: Animals; Arginine; Cattle; Cytochrome c Group; Energy Transfer; Light; Liposomes; Mutagenesis, Site-Directed; Norleucine; Phosphatidylcholines; Protein Binding; Scattering, Radiation; Spectrometry, Fluorescence | 1997 |
A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis.
Topics: Apoptosis; Cell Division; Cells, Cultured; Ceramides; Diacylglycerol Cholinephosphotransferase; Enzyme Inhibitors; Fibroblasts; Fumonisins; Humans; Lysophosphatidylcholines; Lysophospholipids; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Norleucine; Nuclear Proteins; Organophosphates; p38 Mitogen-Activated Protein Kinases; Phosphatidylcholines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Stereoisomerism; Structure-Activity Relationship; Transcription Factors | 2002 |